首页 > 产品中心 > 抗生素

加雷沙星

Garenoxacin

Catalog NO.: KS1169 CAS NO.: 194804-75-6
MDL NO.: EINECS NO.:
分子式: C23H20F2N2O4 分子量: 426.412713050842

搜索质检报告(COA)
搜索MSDS
相关产品

已经到最底了
© 2005-2024 湖南汇百侍生物科技有限公司 版权所有，并保留所有权利
 湘ICP备16010348号
湘公网安备 43019002001003号
技术支持：库价化学(KuuJia)
...

加雷沙星
(R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid;Garenoxacin;(R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-isoindolin-5-yl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid;Ganefloxacin;GARENOXACIN HBR;T-3811;T 3811;Aids080974;Aids-080974;Bms-284756 (*mesylate salt*);Bms 284756 (*mesylate salt*);Garenfloxacin;Garenfloxacin;BMS284756;BMS284756;s5908;s5908;garenoxacine;garenoxacine;garenoxacino;garenoxacino;1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-2-ium-5-yl]-4-oxoquinoline-3-carboxylate;1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-2-ium-5-yl]-4-oxoquinoline-3-carboxylate;garenoxacinum;garenoxacinum;BMS-284756;BMS-284756;SCHEMBL2103727;SCHEMBL2103727;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid;XH1598;XH1598;1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl)-4-oxoquinoline-3-carboxylic acid;1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl)-4-oxoquinoline-3-carboxylic acid;GARENOXACIN [WHO-DD];GARENOXACIN [WHO-DD];BMS 284756 (*Mesylate salt*);BMS 284756 (*Mesylate salt*);HY-17460;HY-17460;NCGC00181770-01;NCGC00181770-01;BMS-284756 (*Mesylate salt*);BMS-284756 (*Mesylate salt*);BCP01415;BCP01415;GARENOXACIN [INN];GARENOXACIN [INN];J-012614;J-012614;(R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2, 3-dihydro-1H-5-isoindolyl)-4-oxo-1, 4-dihydro-3-quinolinecarboxylic acid;(R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2, 3-dihydro-1H-5-isoindolyl)-4-oxo-1, 4-dihydro-3-quinolinecarboxylic acid;EX-A3040;EX-A3040;1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid;1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid;Bms 284756;Bms 284756;GARENOXACIN [MI];GARENOXACIN [MI];1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid;194804-75-6;194804-75-6;DB06160;DB06160;CHEBI:131716;CHEBI:131716;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;J01MA19;J01MA19;AKOS015920281;AKOS015920281;1-cyclopropyl-8-(difluoromethoxy...